0001213900-14-008936.txt : 20141216 0001213900-14-008936.hdr.sgml : 20141216 20141215210309 ACCESSION NUMBER: 0001213900-14-008936 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141216 DATE AS OF CHANGE: 20141215 EFFECTIVENESS DATE: 20141216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XRpro Sciences, Inc. CENTRAL INDEX KEY: 0001518520 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 200982060 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-230172 FILM NUMBER: 141288203 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE, BUILDING 200 STREET 2: SUITE B2002 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-631-8825 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE, BUILDING 200 STREET 2: SUITE B2002 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Caldera Pharmaceuticals Inc DATE OF NAME CHANGE: 20110419 D 1 primary_doc.xml X0707 D LIVE 0001518520 XRpro Sciences, Inc. ONE KENDALL SQUARE, SUITE B2002 CAMBRIDGE MA MASSACHUSETTS 02139 (617) 631-8825 DELAWARE Caldera Pharmaceuticals, Inc. Caldera Pharmaceuticals Inc Corporation true Richard Cunningham One Kendall Square, Suite B2002 Cambridge MA MASSACHUSETTS 02139 Executive Officer Benjamin Warner One Kendall Square, Suite B2002 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Timothy Tyson One Kendall Square, Suite B2002 Cambridge MA MASSACHUSETTS 02139 Director Mark Korb One Kendall Square, Suite B2002 Cambridge MA MASSACHUSETTS 02139 Executive Officer Michael Taglich One Kendall Square, Suite B2002 Cambridge MA MASSACHUSETTS 02139 Director Vincent Palmieri One Kendall Square, Suite B2002 Cambridge MA MASSACHUSETTS 02139 Director Clive Kabatznik One Kendall Square, Suite B2002 Cambridge MA MASSACHUSETTS 02139 Director Edward Roffman One Kendall Square, Suite B2002 Cambridge MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06b false 2014-12-10 false true true true Warrant is exercisable for Common Stock false 10000 Taglich Brothers, Inc. 29102 None None 275 MADISON AVENUE SUITE 1618 NEW YORK NY NEW YORK 10016 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA IA IOWA KS KANSAS MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MO MISSOURI NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO OK OKLAHOMA PA PENNSYLVANIA SC SOUTH CAROLINA SD SOUTH DAKOTA TN TENNESSEE TX TEXAS VA VIRGINIA WA WASHINGTON WI WISCONSIN false 7875000 49000 7826000 false 2 630000 true 0 0 false XRpro Sciences, Inc. /s/ Richard Cunningham Richard Cunningham President and Chief Executive Officer 2014-12-15